European Biotech Acquisit... (EBACW)
NASDAQ: EBACW
· Real-Time Price · USD
0.52
-0.01 (-1.25%)
At close: Mar 02, 2023, 9:56 PM
Company Description
European Biotech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
The company was founded in 2021 and is based in Amsterdam, the Netherlands.
European Biotech Acquisition Corp.
| Country | NL |
| IPO Date | May 11, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Eduardo Bravo Fernandez de Araoz |
Contact Details
Stock Details
| Ticker Symbol | EBACW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001841258 |
| CUSIP Number | G3167F128 |
| ISIN Number | n/a |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 13, 2023 | 15-12G | Filing |
| Mar 02, 2023 | 25-NSE/A | [Amend] Filing |
| Feb 28, 2023 | 8-K | Current Report |
| Feb 28, 2023 | 10-K | Annual Report |
| Feb 21, 2023 | 8-K | Current Report |
| Feb 14, 2023 | DEFA14A | Filing |
| Feb 14, 2023 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Feb 14, 2023 | 8-K | Current Report |
| Feb 13, 2023 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Feb 06, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |